Development of diastolic heart failure in a 6-year follow-up study in patients after acute myocarditis

Heart

Volumn 97, Issue 9, 2011, Pages 709-714

  Escher, Felicitas ^a   Westermann, Dirk ^a   Gaub, Regina ^a   Pronk, Johannes ^a   Bock, Thomas ^b   Al Saadi, Nidal ^c   Uwe Kuhl ^a   Schultheiss, Heinz Peter ^a   Tschöpe, Carsten ^d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c Interdisciplinary Cardiac Imaging Center Berlin   (Germany)

^d Berlin Brandenburg Center for Regenerative Therapies   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEATH; DIASTOLIC HEART FAILURE; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FLOW RATE; FOLLOW UP; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; MALE; MYOCARDITIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RELAXATION TIME; TISSUE DOPPLER IMAGING; VIRUS GENOME;

ACUTE DISEASE; ADULT; FEMALE; GENOME, VIRAL; HEART FAILURE, DIASTOLIC; HOSPITALIZATION; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MYOCARDITIS; PROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79954417949     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.199489     Document Type: Article

References (33)

1. Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003;42:466-72. (Pubitemid 36951713)
2. Kühl U, Pauschinger M, Seeberg M, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005;112:1965-70. (Pubitemid 41377415)
3. D'Ambrosio A, Patti G, Manzoli A, et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001;85:499-504. (Pubitemid 32973488)
4. Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis 2010;52:274-88.
5. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001;104:1076-82. (Pubitemid 32803888)
6. Frustaci A, Pieroni M, Chimenti C. The role of endomyocardial biopsy in the diagnosis of cardiomyopathies. Ital Heart J 2002;3:348-53. (Pubitemid 34823290)
7. Ardehlali H, Qasim A, Cappola T, et al. Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. Am Heart J 2004;147:919-23. (Pubitemid 38881009)
8. Cooper LT, Baughman KL, Feldman AM, et al; American College of Cardiology European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007;116:2216-33. (Pubitemid 350060359)
9. Kasner M, Westermann D, Steendijk P, et al. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Dopplereconductance catheterization study. Circulation 2007;116:637-47. (Pubitemid 47356348)
10. Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-50. (Pubitemid 47614269)
11. Swedberg K, Cleland J, Dargie H, et al. Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-40. (Pubitemid 40839912)
12. Kühl U, Noutsias M, Seeberg B, et al. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 1996;75:295-300. (Pubitemid 26094969)
13. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis: a histopathological definition and classification. Am J Cardiovasc Pathol 1987;1:3-14.
14. Escher F, Kuhl U, Sabi T, et al. Immunohistological detection of parvovirus B19 capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients. Med Sci Monit 2008;14:333-8.
15. Noutsias M, Pauschinger M, Ostermann K, et al. Digital image analysis system for quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy. Med Sci Monit 2002;8:59-71.
16. Gutberlet M, Spors B, Thoma T, et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008;246:401-9.
17. McCarthy RE, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690-5. (Pubitemid 30131421)
18. Caforio AL, Calabrese F, Angelini A, et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 2007;8:326-33.
19. Tschöpe C, Kasner M, Westermann D, et al. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J 2005;26:2277-84. (Pubitemid 41541392)
20. Grewal J, McKelvie RS, Persson H, et al. Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Am J Cardiol 2008;102:733-7.
21. Watanabe S, Shite J, Takaoka H, et al. Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure. Eur Heart J 2006;27:832-8.
22. Fischer M, Beassler A, Hense HW, et al. Prevalence of left ventricular diastolic dysfunction in the community: results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003;24:320-8. (Pubitemid 36215965)
23. Klapholz M, Maurer M, Lowe AM, et al. New York Heart Failure Consortium. Hospitalization for heart failure in the presence of normal left ventricular ejection fraction: results of New York Heart Failure Registry. J Am Coll Cardiol 2004;43:1432-8. (Pubitemid 38496351)
24. Kindermann I, Kindermann M, Kandolf R, et al. Predictors of outcome of patients with suspected myocarditis. Circulation 2008;118:639-48.
25. Heymans S, Pauschinger M, De Palma A, et al. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. Circulation 2006;114:565-73. (Pubitemid 44199646)
26. Kawaguchi M, Hay I, Fetics B, et al. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003;107:714-20. (Pubitemid 36222599)
27. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure, part II: causal mechanisms and treatment. Circulation 2002;105:1503-8. (Pubitemid 34263285)
28. van Heerebeek L, Hamdani N, Handoko ML, et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008;117:43-51. (Pubitemid 350291180)
29. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9. (Pubitemid 44079340)
30. Varadarajan P, Pai RG. Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients. J Card Fail 2003;9:107-12. (Pubitemid 36444195)
31. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995;26:1565-74.
32. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355:260-9. (Pubitemid 44088349)
33. Schaefer A, Meyer GP, Fuchs M, et al. Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial. Eur Heart J 2006;27:929-35.